Abstract The coronavirus disease 2019 (COVID-19) has been ongoing outbreak and
declared as a global public health emergency by the World Health Organization. Severe and …

Background Based on current evidence, recent guidelines of the National Institute of Health,
USA indicated the use of remdesivir and dexamethasone for the treatment of COVID-19 …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel coronavirus, and
its infection, coronavirus disease 2019 (COVID-19), have quickly become a worldwide …

Therapeutics for hospitalized COVID-19 patients were identified through a robust research
response with several lessons learned: clinical trial data should guide therapeutic use …

Now the world stands in the fight against coronavirus disease 2019 (COVID-19), with its
early origin from Wuhan city in China. It has evolved into a global pandemic resulting into a …

Importance: Currently, there is no unified framework linking disease progression to
established viral levels, clinical tests, inflammatory markers, and investigational treatment …

In less than 3 years, more than 6 million people died from COVID-19. If no panacea has
been discovered yet, the joint effort of the worldwide scientific community has enabled the …

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the most recently
discovered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The outbreak …

ABSTRACT Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) represents the most significant global public health …

Objectives The purpose of this study is to test the safety and effectiveness of individually or
simultaneously blocking IL-6, IL-6 receptor and IL-1 versus standard of care on blood …